Pillstats
Rx only · Tablet, Delayed Release · Oral

Naproxen And Esomeprazole Magnesium

Esomeprazole Magnesium + Naproxen

9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US19 NDCs
9 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)283742
US makers9 labelers
Packages40
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.760$1.52$2.28$3.04Dec 2025Apr 2026Jul 2026
$2.593
Latest avg · Jul 22, 2026
+21%
Since Dec 17, 2025
9
Active US suppliers
40%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

6021.2K1.8K2.4K2025 Q12025 Q22025 Q32025 Q42026 Q1
854
Rx · 2026 Q1
57K
Units dispensed
-59%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it9 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Asclemed USA, Inc.unknown8SUPPLYING
PHOENIX RX LLCunknown8SUPPLYING
ScieGen Pharmaceuticals, Inc.unknown6SUPPLYING
Preferred Pharmaceuticals Inc.unknown6SUPPLYING
Bryant Ranch Prepackrepackager6SUPPLYING
Dr.Reddy's laboratories Limitedunknown2SUPPLYING
Ajanta Pharma USA Inc.unknown2SUPPLYING
Proficient Rx LPunknown1SUPPLYING
Doc Rxunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.